You just read:

Cell>Point plans to expedite research program on 99mTc-EC-Amifostine and 177Lu-EC-Amifostine as a potentially effective theranostic technology for COVID-19

News provided by

CellPoint, L.L.C.

Mar 24, 2020, 11:04 ET